These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38164615)

  • 61. Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2
    Ikeda S; Sugiyama H; Tokuhara H; Murakami M; Nakamura M; Oguro Y; Aida J; Morishita N; Sogabe S; Dougan DR; Gay SC; Qin L; Arimura N; Takahashi Y; Sasaki M; Kamada Y; Aoyama K; Kimoto K; Kamata M
    J Med Chem; 2021 Aug; 64(15):11014-11044. PubMed ID: 34328319
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification and characterization of a new reversible MAGL inhibitor.
    Tuccinardi T; Granchi C; Rizzolio F; Caligiuri I; Battistello V; Toffoli G; Minutolo F; Macchia M; Martinelli A
    Bioorg Med Chem; 2014 Jul; 22(13):3285-91. PubMed ID: 24853323
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preclinical Development of
    Ahmed H; Wallimann R; Haider A; Hosseini V; Gruber S; Robledo M; Nguyen TAN; Herde AM; Iten I; Keller C; Vogel V; Schibli R; Wünsch B; Mu L; Ametamey SM
    J Nucl Med; 2021 Feb; 62(2):259-265. PubMed ID: 32737247
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism.
    Long JZ; Nomura DK; Cravatt BF
    Chem Biol; 2009 Jul; 16(7):744-53. PubMed ID: 19635411
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET.
    Shalgunov V; van Wieringen JP; Janssen HM; Fransen PM; Dierckx RA; Michel MC; Booij J; Elsinga PH
    J Nucl Med; 2015 Jan; 56(1):133-9. PubMed ID: 25476538
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical Characterization of [
    Constantinescu CC; Brown T; Wang S; Yin W; Barret O; Jennings D; Tauscher J
    J Nucl Med; 2023 Dec; 64(12):1972-1979. PubMed ID: 37770111
    [TBL] [Abstract][Full Text] [Related]  

  • 67. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Holtfrerich A; Hanekamp W; Lehr M
    Eur J Med Chem; 2013 May; 63():64-75. PubMed ID: 23455058
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthesis and evaluation of carbamate derivatives as fatty acid amide hydrolase and monoacylglycerol lipase inhibitors.
    Jaiswal S; Gupta G; Ayyannan SR
    Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200081. PubMed ID: 35924298
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neuronal and Astrocytic Monoacylglycerol Lipase Limit the Spread of Endocannabinoid Signaling in the Cerebellum.
    Chen Y; Liu X; Vickstrom CR; Liu MJ; Zhao L; Viader A; Cravatt BF; Liu QS
    eNeuro; 2016; 3(3):. PubMed ID: 27182552
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet.
    Terrone G; Pauletti A; Salamone A; Rizzi M; Villa BR; Porcu L; Sheehan MJ; Guilmette E; Butler CR; Piro JR; Samad TA; Vezzani A
    Epilepsia; 2018 Jan; 59(1):79-91. PubMed ID: 29171003
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine.
    Della Pietra A; Giniatullin R; Savinainen JR
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530477
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Effect of monoacylglycerol lipase with proliferation of MHCC97H human liver cancer cells in vivo].
    Zhu WP; He XG; Zhao YM; Pan Q; Zhang N; Zhou JM; Wang LR; Wang M; Liu ZY; Zhu HX; Wang L
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):516-520. PubMed ID: 31357777
    [No Abstract]   [Full Text] [Related]  

  • 73. Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase.
    Aaltonen N; Savinainen JR; Ribas CR; Rönkkö J; Kuusisto A; Korhonen J; Navia-Paldanius D; Häyrinen J; Takabe P; Käsnänen H; Pantsar T; Laitinen T; Lehtonen M; Pasonen-Seppänen S; Poso A; Nevalainen T; Laitinen JT
    Chem Biol; 2013 Mar; 20(3):379-90. PubMed ID: 23521796
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A fluorescence-based assay for monoacylglycerol lipase compatible with inhibitor screening.
    Wang Y; Chanda P; Jones PG; Kennedy JD
    Assay Drug Dev Technol; 2008 Jun; 6(3):387-93. PubMed ID: 18452392
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Monoacylglycerol Lipase: A Novel Potential Therapeutic Target and Prognostic Indicator for Hepatocellular Carcinoma.
    Zhang J; Liu Z; Lian Z; Liao R; Chen Y; Qin Y; Wang J; Jiang Q; Wang X; Gong J
    Sci Rep; 2016 Oct; 6():35784. PubMed ID: 27767105
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of [¹⁸F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human.
    Hostetler ED; Sanabria-Bohórquez S; Eng W; Joshi AD; Patel S; Gibson RE; O'Malley S; Krause SM; Ryan C; Riffel K; Bi S; Okamoto O; Kawamoto H; Ozaki S; Ohta H; de Groot T; Bormans G; Depré M; de Hoon J; De Lepeleire I; Reynders T; Cook JJ; Burns HD; Egan M; Cho W; van Laere K; Hargreaves RJ
    Neuroimage; 2013 Mar; 68():1-10. PubMed ID: 23238431
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis.
    Hernández-Torres G; Cipriano M; Hedén E; Björklund E; Canales Á; Zian D; Feliú A; Mecha M; Guaza C; Fowler CJ; Ortega-Gutiérrez S; López-Rodríguez ML
    Angew Chem Int Ed Engl; 2014 Dec; 53(50):13765-70. PubMed ID: 25298214
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors.
    Poli G; Lapillo M; Jha V; Mouawad N; Caligiuri I; Macchia M; Minutolo F; Rizzolio F; Tuccinardi T; Granchi C
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):589-596. PubMed ID: 30696302
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Set-Up and Validation of a High Throughput Screening Method for Human Monoacylglycerol Lipase (MAGL) Based on a New Red Fluorescent Probe.
    Miceli M; Casati S; Ottria R; Di Leo S; Eberini I; Palazzolo L; Parravicini C; Ciuffreda P
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31208066
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Preclinical Evaluation and Quantification of
    Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
    J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.